Targeted therapy for rare cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients with rare malignant neoplasms who may benefit from precision cancer therapy. It employs advanced molecular diagnostics to identify targetable alterations in tumor cells by analyzing over 500 genes at the DNA and RNA levels. Based on these molecular characteristics, patients will receive targeted treatments such as Imatinib, Trametinib, or Dabrafenib. The goal is to improve treatment outcomes for patients with hard-to-treat cancers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ECOG 0-2,
* identified biomarker,
* reasonable biochemistry

Exclusion Criteria:

* ECOG 3-5
* serious other diseases

Where it's running

• Oslo University Hospital
  Oslo, Norway Recruiting

Study contacts

• Study coordinator: Åslaug Helland, MD PhD
• Email: ahelland@medisin.uio.no
• Phone: +4795940863

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Collecting data on rare and complex tumors in the thoraco-abdominal region

  This study is collecting information on rare and complex tumors in the chest and abdomen to better understand how they are diagnosed, treated, and followed up over time.

  Recruiting at 2 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, BO and 1 other locations · NCT06872853

• Registry for patients with advanced rare cancers in Asia

  This study is collecting information from patients with advanced rare cancers in Asia to see how different treatments work and to find better, personalized options for their care.

  Recruiting at 16 sites National Cancer Center, Japan · Chuo-ku, Tokyo and 17 other locations · NCT05217407

• Proton Re-irradiation for Recurrent or Second Primary Head and Neck Cancer

  This study tests proton radiotherapy to see if it can control head and neck cancer that has come back or appeared again in the same area, while trying to limit side effects.

  Recruiting Oslo University Hospital · Bergen and 3 other locations · NCT07922967

• Predicting high-risk arrhythmic events in people with arrhythmic mitral valve prolapse

  This study tests a risk model to see which patients with arrhythmic mitral valve prolapse might need an ICD.

  Recruiting Oslo University Hospital · Oslo · NCT07830888

• Digital long-term follow-up for heart disease survivors using HeartCheck

  A smartphone-based program called HeartCheck is tested to help adults who survived a recent heart attack or PCI stay on top of risk factors and medications over time.

  Recruiting at 2 sites Oslo University Hospital · Arendal and 1 other locations · NCT07720349

• Biomarker tests in adults with lupus to see how kidney disease changes over time

  Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.

  Recruiting Oslo University Hospital · Oslo, Oslo · NCT07666711

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.